0001601485-18-000002.txt : 20180717 0001601485-18-000002.hdr.sgml : 20180717 20180717161441 ACCESSION NUMBER: 0001601485-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180717 DATE AS OF CHANGE: 20180717 EFFECTIVENESS DATE: 20180717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Angion Biomedica Corp. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-317100 FILM NUMBER: 18956647 BUSINESS ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 BUSINESS PHONE: (516) 326-1200 MAIL ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 D 1 primary_doc.xml X0708 D LIVE 0001601485 Angion Biomedica Corp. 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY NEW YORK 11553 (516) 326-1200 DELAWARE None None Corporation true Itzhak D. Goldberg 51 Charles Lindbergh Boulevard Uniondale NY NEW YORK 11553 Executive Officer Director Chairman and Secretary Jay Venkatesan 51 Charles Lindbergh Boulevard Uniondale NY NEW YORK 11553 Executive Officer Director Chief Executive Officer Michael Yamin 51 Charles Lindbergh Boulevard Uniondale NY NEW YORK 11553 Director Biotechnology Decline to Disclose 06b false 2018-07-05 false true true true false 15000 GP Nurmenkari Inc. 153480 None None 22 Elizabeth Street SONO Square, Suite 1J Norwalk CT CONNECTICUT 06854 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO PA PENNSYLVANIA RI RHODE ISLAND TX TEXAS WI WISCONSIN false H.C. Wainright & Co., LLC 375 None None 430 Park Avenue New York NY NEW YORK 10022 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO PA PENNSYLVANIA RI RHODE ISLAND TX TEXAS WI WISCONSIN false T.R. Winston & Company, LLC 10571 None None 2049 Century Park East Suite 320 Los Angeles CA CALIFORNIA 90067 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO PA PENNSYLVANIA RI RHODE ISLAND TX TEXAS WI WISCONSIN false 35000000 15379000 19621000 Includes $5,000,000 over-allotment option granted to the placement agents. The total offering amount does not include the conversion of promissory notes into Units for which no commission was paid, as it was not completed through the placement agents. false 133 3000000 0 Sales commission assumes offering is fully subscribed. Each placement agent ("PA") will also receive unit warrants equal to 10% of the total Units sold by such PA, with GPN receiving a bonus of 50,000 unit warrants if they sell more than $10M of Units. 0 false Angion Biomedica Corp. /s/ Jay Venkatesan Jay Venkatesan Chief Executive Officer 2018-07-17